Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041866 | SCV000065562 | benign | not specified | 2010-08-17 | criteria provided, single submitter | clinical testing | Val191Val in exon 3 of USH2A: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue, is not located near a splice junction, is listed in dbSNP (rs73102592 - no frequency data), and is rep orted as benign in one publication (Bernal 2005). |
Labcorp Genetics |
RCV000953435 | SCV001100008 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001097447 | SCV001253729 | benign | Usher syndrome type 2A | 2019-03-20 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001097448 | SCV001253730 | benign | Retinitis pigmentosa | 2019-03-20 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000953435 | SCV001885726 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000953435 | SCV003800315 | benign | not provided | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450857 | SCV004182971 | benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001097447 | SCV004182972 | benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003888400 | SCV004708082 | benign | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
Breakthrough Genomics, |
RCV000953435 | SCV005280619 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001097447 | SCV001457331 | benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |